期刊文献+

青蒿素作用前后K562细胞基因表达谱的改变 被引量:2

An alteration in the gene expression profiling of K562 cells after treatment with artemisinin
下载PDF
导出
摘要 目的:利用基因表达谱芯片研究青蒿素对体外培养的人红白血病K562细胞基因表达谱的影响。方法:青蒿素处理K562细胞24h后,分别提取处理组和对照组细胞的总RNA,将两组RNA纯化为mRNA,逆转录成cDNA,用Cy3和Cy5两种不同的荧光染料进行线性扩增标记,与人全基因组基因表达谱芯片杂交,采用生物信息学方法分析青蒿素处理前后K562细胞基因表达谱的改变。结果:总共发现差异基因238个,其中上调基因136个,下调基因102个,并对其进行生物学功能分类。结论:应用全基因组表达谱芯片并结合Panther生物学软件分析差异表达基因,青蒿素作用K562细胞主要是通过细胞毒作用诱导细胞凋亡,而抑制细胞生长作用并不明显。 Objective To investigate the effect of artemisinin on the gene expression profile of human erythroleukemia K562 cells cultured in vitro. Methods The total RNAs were extracted from K562 cells treated with ART for 24 hours and from the control K562 cells. All the RNAs were purified into mRNA and then converted to double-stranded cDNAs by reverse transcription. The cDNAs were labeled with a fluorescence dye Cy3 or Cy5 and hybridized to a human whole-genome oligonucleotide microarray. The change in the gene expression profiling of K563 cells following treatment with artemisinin was analyzed by using bioinformatics. Results A total of 238 differential genes were found, 136 of which were up-regulated and 102 were down-regulated. Their biologic function was classified. Conclusions By analyzing the differential gene expressions with the whole-genome oligonucleotide microarray combined with the Panther software, we find that artemisinin induces the apoptosis of K562 cells by its cytotoxic effect on the cells and that the inhibitory effect of artemisinin on the cell growth is not evident.
出处 《实用医学杂志》 CAS 北大核心 2009年第6期852-854,共3页 The Journal of Practical Medicine
基金 广东省重点实验室建设经费资助项目(编号:2004B60144)
关键词 青蒿素 基因芯片 基因表达谱 K562 Artemisinin Microarray Gene expression profiling K562
  • 相关文献

参考文献7

  • 1郭建红,丘明建.青蒿素类衍生物抗肿瘤研究进展[J].中国现代药物应用,2008,2(1):123-125. 被引量:5
  • 2蒋永新,王熙才,金从国,陈晓群,伍治平,李新,李佳.双氢青蒿素对人肺鳞癌细胞株YTMLC抑制作用的实验研究[J].临床肿瘤学杂志,2006,11(10):730-734. 被引量:13
  • 3董海鹰,王知非,宋维华,王玲,杨宝峰.青蒿素诱导K562细胞凋亡研究[J].中国肿瘤,2003,12(8):473-475. 被引量:41
  • 4Singh N P, Lai H. Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer ceils [J]. Life Science, 2001, 70( 1 ) :49-56.
  • 5Efferth A. Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells [J]. Curr Drug Targets, 2006, 7(4): 407-421.
  • 6Disbrow G L, Baege A C, Kierpiec K A, et al. Dihydroartemisinin is cytotoxic to papillomavirus-expressing epithelial cells in vitro and in vivo [J]. Cancer Res, 2005, 65(23) : 10854-10861.
  • 7Sing N P, Lai H C. Synergistic cytotoxicity of artemisinin and sodium butyrate on human cancer cells [J]. Anticancer Res,2005,25(68) : 4325-4331.

二级参考文献23

  • 1赵莉霞,颜冰,黄培堂.转铁蛋白受体及其在药物运输中的作用[J].生命的化学,2004,24(6):468-469. 被引量:4
  • 2谢波,凌家俊.青蒿素及其衍生物抗肿瘤作用综述[J].广州中医药大学学报,2005,22(1):75-77. 被引量:11
  • 3[1]Wiesner,J,Ortmann,R,Jomaa,H,Schlitzer,M,2003.Newantimalarial drugs.Angew.Chem.Int.Ed.Engl.42,5274-5293.
  • 4[2]Meshnick,S.R,2002.Artemisinin:mechanisms of action,resistance and toxicity.Int.J.Parasitol.32,1655-1660.
  • 5[3]Dhingra,V,Vishweshwar Rao,K,Lakshmi Narasu,M,2000.Current status of artemisinin and its derivatives as antimalarial drugs.Life Sci.66,279-300.
  • 6[5]William J.The evolution of transferring.Trend Biochem.Sci,1982,7(11):394-397.
  • 7[8]Mamta Srivastava,Nils O,Petersen U.Diffusion of transferrin receptor clusters.Biophysical Chemistry,1998,75:201-211.
  • 8[9]Oxidative stress response of tumor cells:microarray-based comparison between artemisinins and anthracyclines.Biochem Pharmacol,2004,68(1):3-10.
  • 9[10]Moore,J.C,Lai,H,Li,J.R,Ren,R.L,McDougall,J.A,Singh,N.P,Chou,C.K,1995.Oral administration of dihydroartemisinin and ferrous sulfate retarded implanted fibrosarcoma growth in the rat.Cancer Lett,1998,83 -87.
  • 10[11]Lai,H,Singh,N.P,2006.Oral artemisinin prevents and delays the development of 7,12-dimethylbenz[a] ant-hracene (DMBA) -induced breast cancer in the rat.Cancer Lett.231,43-48.

共引文献56

同被引文献18

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部